| Date Filed | Type | Description |
| 08/16/2023 |
4
| Anderson Glen R. (10% Owner) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Bought 44,354 shares
@ $1.94, valued at
$86k
Bought 35,064 shares
@ $2.12, valued at
$74.3k
Bought 23,934 shares
@ $2.34, valued at
$56k
|
|
| 08/07/2023 |
4
| Waltzman Roger J. (Chief Medical Officer) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 90,000 options to buy
@ $1.85, valued at
$166.5k
|
|
| 08/07/2023 |
3
| Waltzman Roger J. (Chief Medical Officer) has filed a Form 3 on Indaptus Therapeutics, Inc. |
| 02/14/2023 |
4
| Martell Robert (Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.71, valued at
$34.2k
|
|
| 02/14/2023 |
3
| Martell Robert (Director) has filed a Form 3 on Indaptus Therapeutics, Inc. |
| 01/20/2023 |
4
| Meckler Jeffrey A (CEO and Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.61, valued at
$161k
|
|
| 01/20/2023 |
4
| Linscott Walt Addison (Chief Business Officer) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.61, valued at
$64.4k
|
|
| 01/20/2023 |
4
| Sassi Nir (CFO) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.61, valued at
$64.4k
|
|
| 01/20/2023 |
4
| Newman Michael James (CSO and Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 43,250 options to buy
@ $1.61, valued at
$69.6k
|
|
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2022 |
4
| Meckler Jeffrey A (CEO and Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Bought 400 shares
@ $1.7637, valued at
$705.5
Bought 9,600 shares
@ $1.9, valued at
$18.2k
|
|
| 10/03/2022 |
4
| Karah Hila (Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 13,750 options to buy
@ $2.16, valued at
$29.7k
|
|
| 10/03/2022 |
4
| Pomerantz Roger (Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 81,000 options to buy
@ $2.16, valued at
$175k
|
|
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| O'CALLAGHAN BRIAN (Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 13,750 options to buy
@ $2.16, valued at
$29.7k
|
|
| 10/03/2022 |
4
| MADDALUNA ANTHONY J (Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 13,750 options to buy
@ $2.16, valued at
$29.7k
|
|
| 10/03/2022 |
4
| Hayes William B (Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 13,750 options to buy
@ $2.16, valued at
$29.7k
|
|
| 09/12/2022 |
4
| Meckler Jeffrey A (CEO and Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Bought 10,308 shares
@ $2.8, valued at
$28.9k
|
|
| 09/09/2022 |
4
| Linscott Walt Addison (Chief Business Officer) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Bought 150 shares
@ $2.62, valued at
$393 |
|
| 09/08/2022 |
4
| Meckler Jeffrey A (CEO and Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Bought 1,060 shares
@ $2.44, valued at
$2.6k
Bought 8,632 shares
@ $2.57, valued at
$22.2k
|
|
| 07/07/2022 |
3
| Anderson Glen R. (10% Owner) has filed a Form 3 on Indaptus Therapeutics, Inc. |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Litchev Boyan Vesselinov (Chief Medical Officer) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 90,000 options to buy
@ $4.97, valued at
$447.3k
|
|
| 02/02/2022 |
3
| Litchev Boyan Vesselinov (Chief Medical Officer) has filed a Form 3 on Indaptus Therapeutics, Inc. |
| 02/02/2022 |
4
| Newman Michael James (CSO and Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Sold 5,870 shares
@ $5.0001, valued at
$29.4k
Sold 14,130 shares
@ $5.003, valued at
$70.7k
|
|
| 01/28/2022 |
4
| Newman Michael James (CSO and Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 43,350 options to buy
@ $4.9, valued at
$212.4k
|
|
| 01/28/2022 |
4
| Meckler Jeffrey A (CEO and Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $4.9, valued at
$980k
|
|
| 01/28/2022 |
4
| Linscott Walt Addison (Chief Business Officer) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 45,850 options to buy
@ $4.9, valued at
$224.7k
|
|
| 12/08/2021 |
4
| Gilbert Mark John (Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $5.35, valued at
$107k
|
|
| 12/08/2021 |
3
| Gilbert Mark John (Director) has filed a Form 3 on Indaptus Therapeutics, Inc. |
| 11/19/2021 |
4
| Meckler Jeffrey A (CEO and Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Bought 11,187 shares
@ $5.82, valued at
$65.1k
|
|
| 09/16/2021 |
4
| Meckler Jeffrey A (CEO and Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Bought 12,000 shares
@ $7, valued at
$84k
|
|
| 08/06/2021 |
4
| O'CALLAGHAN BRIAN (Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 13,750 options to buy
@ $8.87, valued at
$122k
|
|
| 08/06/2021 |
4
| Sassi Nir (CFO) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $8.87, valued at
$310.5k
|
|
|